54 Participants Needed

Ankle Foot Orthoses for Foot Injuries

(AFOCE Trial)

Recruiting at 2 trial locations
JM
Overseen ByJason M. Wilken, PT, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Jason Wilken
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is testing two types of custom-fit carbon fiber leg braces to help adults who had serious lower leg injuries and still have trouble moving. The braces are designed to give extra support and make it easier to walk. Researchers will compare how well each brace works by measuring things like balance, speed, and comfort.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment PhatBrace AFO, Reaktiv AFO for foot injuries?

Research shows that ankle-foot orthoses (AFOs) can help improve balance and reduce the risk of falls in people with certain conditions, like after a stroke. Additionally, AFOs have been effective in treating severe ankle sprains, allowing most patients to return to activity without restrictions in a few months.12345

How is the PhatBrace AFO, Reaktiv AFO treatment different from other treatments for foot injuries?

The PhatBrace AFO and Reaktiv AFO are unique because they are designed to improve balance and walking ability by providing specific ankle support, which can be particularly beneficial for those with compromised balance or spasticity. Unlike standard treatments, these orthoses may offer tailored stiffness and support to enhance mobility and reduce fall risk.16789

Research Team

JM

Jason M. Wilken, PT, PhD

Principal Investigator

University of Iowa

Eligibility Criteria

This trial is for adults aged 18-65 who have had a severe lower leg injury below the knee over two years ago, can walk at least 50 feet without support, and are experiencing mechanical pain. They must not be pregnant, require a knee stabilizing device for daily activities, or have conditions that would interfere with testing like severe brain injuries or heart conditions.

Inclusion Criteria

Able to read and write in English and provide written informed consent
I have limited movement in my ankle without pain.
I am considered for amputation due to severe ankle/foot problems.
See 6 more

Exclusion Criteria

Pregnancy- Per participant self-report. Due the expected small number of pregnant individuals and resulting inability to account for its effect on resulting outcomes participants will be withdrawn from the study.
I need a device to help stabilize my knee for daily activities.
I have ankle weakness due to a spinal cord injury or brain condition.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Evaluation

Participants are evaluated under conditions with no device and standard of care

1 week
1 visit (in-person)

Treatment - Reaktiv Accommodation

Participants are accommodated to the Reaktiv AFO for evaluation

3 months
Multiple visits (in-person)

Treatment - PhatBrace Accommodation

Participants are accommodated to the PhatBrace AFO for evaluation

3 months
Multiple visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

Treatment Details

Interventions

  • PhatBrace AFO
  • Reaktiv AFO
Trial Overview The study compares two custom-fit carbon fiber braces: Reaktiv AFO and PhatBrace AFO. It aims to determine which brace better improves function after serious lower leg injuries by assessing their form, fit, and function in participants' outcomes.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: BAExperimental Treatment2 Interventions
Participants in this arm will receive the PhatBrace AFO by Bio-Mechanical Composites Inc. first, then the Reaktiv AFO made by FabTech Systems LLC second.
Group II: ABExperimental Treatment2 Interventions
Participants in this arm will receive the Reaktiv AFO made by FabTech Systems LLC first, then the PhatBrace AFO by Bio-Mechanical Composites Inc. second.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jason Wilken

Lead Sponsor

Trials
2
Recruited
90+

Minneapolis Veterans Affairs Medical Center

Collaborator

Trials
77
Recruited
355,000+

Walter Reed National Military Medical Center

Collaborator

Trials
149
Recruited
33,800+

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborator

Trials
103
Recruited
94,300+

Center for Veterans Research and Education

Collaborator

Trials
13
Recruited
1,700+

University of Delaware

Collaborator

Trials
167
Recruited
25,700+

Johns Hopkins Bloomberg School of Public Health

Collaborator

Trials
441
Recruited
2,157,000+

Findings from Research

The study involving 25 chronic post-stroke hemiparetic patients demonstrated that using prefabricated thermoplastic posterior leaf spring ankle foot orthoses (PLS-AFO) significantly improved balance, as indicated by an increase in Berg Balance Scale scores from 42.12 without AFO to 47.52 with AFO.
The use of PLS-AFO also reduced fall risk, with stability scores improving from 3.35 without AFO to 2.69 with AFO, highlighting its effectiveness in enhancing safety for patients with mild to moderate spasticity.
The ankle-foot orthosis improves balance and reduces fall risk of chronic spastic hemiparetic patients.Cakar, E., Durmus, O., Tekin, L., et al.[2016]
A survey of 100 UK orthotists revealed a strong consensus on the design of rigid ankle-foot orthoses (AFOs) for adult men, emphasizing the use of 4.5 mm copolymer polypropylene and a full-length footplate for optimal support.
The study identified specific design features, such as padded VELCRO straps and a height that finishes 2 cm below the fibular head, which are considered important for effective AFO prescription and patient comfort.
Prescription practices for rigid ankle-foot orthoses among UK orthotists.Eddison, N., Gandy, M., Charlton, P., et al.[2023]
In a study involving 105 stroke patients, the therapist-made SWIFT Cast AFO was used significantly more during physical therapy sessions compared to conventional AFOs, indicating better integration into rehabilitation.
Despite higher usage of the SWIFT Cast, there was no significant improvement in walking speed compared to conventional therapy, suggesting that while it is a low-cost and adaptable option, it may not enhance recovery outcomes beyond standard treatments.
A Randomized Controlled Evaluation of the Efficacy of an Ankle-Foot Cast on Walking Recovery Early After Stroke: SWIFT Cast Trial.Pomeroy, VM., Rowe, P., Clark, A., et al.[2022]

References

The ankle-foot orthosis improves balance and reduces fall risk of chronic spastic hemiparetic patients. [2016]
Prescription practices for rigid ankle-foot orthoses among UK orthotists. [2023]
A Randomized Controlled Evaluation of the Efficacy of an Ankle-Foot Cast on Walking Recovery Early After Stroke: SWIFT Cast Trial. [2022]
Severe Ankle Sprains. [2016]
Ankle-foot orthotic management in neuromuscular disorders: recommendations for future research. [2022]
The impact of ankle-foot orthosis stiffness on gait: A systematic literature review. [2022]
The Impact of Ankle-foot Orthoses on Balance in Older Adults: a Scoping Review. [2023]
A new model of plastic ankle foot orthosis (FAFO (II)) against spastic foot and genu recurvatum. [2017]
Effects of joint alignment and type on mechanical properties of thermoplastic articulated ankle-foot orthosis. [2014]